For decades, the Centers for Disease Control and Prevention (CDC) operated under a mandate of relative transparency, allowing the public to observe the granular—and often contentious—deliberations that shape national health policy. These meetings served as a rare bridge between high-level scientific consensus and the citizens affected by it, offering a window into how data is weighed and debated.
However, that era of open-door policy appears to be receding. For the first time, a key CDC conference that has historically been open to the public is moving behind closed doors. The shift marks a significant departure from the agency’s long-standing tradition of accessibility, signaling a move toward a more insulated administrative posture.
The decision comes at a precarious moment for public health authorities. In an environment defined by institutional skepticism and the rapid politicization of medical guidance, the visibility of the decision-making process is often as vital as the decisions themselves. By limiting access, the agency risks prioritizing internal efficiency over the performance of accountability, potentially widening the trust gap that has characterized the post-pandemic landscape.
With reporting from STAT News.
Source · STAT News (Biotech)
